AstraZeneca (AZN) Dividend Yield, Date & History £104.92 +74.00 (+0.71%) As of 12:30 PM Eastern Add Compare Share Share Dividend Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock AstraZeneca Dividend SummaryDividend Yield2.23%Annual DividendGBX 234Recent Dividend Payment Sep. 9 Dividend Payout Ratio 64.14% AstraZeneca (AZN) pays an annual dividend of GBX 234 per share, with a dividend yield of 2.23%. The most recent payment of GBX 77.60 per share was paid on Monday, September 9, to investors who owned the stock before the ex-dividend date of Thursday, August 8. The company currently pays out 64.14% of its earnings and 86.74% of its cash flow as dividends. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Enter your email to sign up for newsletter Sign Up Skip Charts & View Dividend HistoryAZN Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of AstraZeneca's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open AstraZeneca in Dividend Calculator AZN Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks AstraZeneca's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open AstraZeneca in Dividend Yield Calculator AstraZeneca vs. The CompetitionCompare AstraZeneca's annual dividend, yield, and 3-year growth rate with averages for Medical and LON companies to evaluate its performance against the market.TypeAstraZenecaMedical CompaniesLON CompaniesAnnual DividendGBX 234GBX 0.05GBX 27.43Dividend Yield2.23%5.22%5.05%AstraZeneca Dividend Payout RatioDividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.TypePayout RatioBased on Trailing 12 Months of Earnings64.14%Based on This Year's Estimate32.07%Based on Cashflow86.74% AstraZeneca Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame * Start Date * End Date AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date7/25/2024GBX 77.60-GBX 78.4050.26%0.64%8/8/20248/8/20249/9/20242/8/2024GBX 156+GBX 84.20117.27%1.49%2/22/20242/22/20243/25/20247/28/2023GBX 71.80-GBX 9155.90%0.67%8/10/20238/10/20239/11/2023This table shows AstraZeneca's dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. AstraZeneca Dividend - Frequently Asked Questions What is AstraZeneca's dividend yield? The current dividend yield for AstraZeneca is 2.23%. Learn more on AZN's dividend yield history. How much is AstraZeneca's annual dividend? The annual dividend for AZN shares is GBX 234. Learn more on AZN's annual dividend history. When was AstraZeneca's most recent dividend payment? AstraZeneca's most recent dividend payment of GBX 77.60 per share was made to shareholders on Monday, September 9, 2024. When was AstraZeneca's most recent ex-dividend date? AstraZeneca's most recent ex-dividend date was Thursday, August 8, 2024. When did AstraZeneca last increase or decrease its dividend? The most recent change in the company's dividend was a decrease of GBX 78.40 on Thursday, July 25, 2024. What is AstraZeneca's dividend payout ratio? The dividend payout ratio for AZN is: 64.14% based on the trailing year of earnings 32.07% based on this year's estimates 86.74% based on cash flow Is AstraZeneca a good dividend stock? AstraZeneca's dividend yield of 1.23% is lower than the average Medical company that issues a dividend. AstraZeneca's dividend payout ratio of 64.14% is at a healthy, sustainable level, below 75% of its earnings. Looking at the stock as a whole, market analysts rate AstraZeneca stock as a Moderate Buy, forecasting growth opportunities and potential value appreciation. More Dividend Resources from MarketBeat Related Companies GSK Dividend Yield Ithaca Energy Dividend Yield Grainger Dividend Yield Bloomsbury Publishing Dividend Yield Origin Enterprises Dividend Yield Alpha Real Trust Dividend Yield Pharos Energy Dividend Yield Marks Electrical Group Dividend Yield RiverFort Global Opportunities Dividend Yield Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Aristocrats Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles 3 Dividend-Friendly Consumer Discretionary Stocks With UpsideIs Verizon a Buy? Q1 Results and Solid Dividend Make Bullish CaseDividends & Stability: 3 Consumer Staples Giants Boost Payouts3 Dividend Kings Outshining the Market in 2025Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025Dividend King Kimberly-Clark Is a Good Buy in 2025Medtronic: A Dividend Aristocrat With Stability and InnovationSnap-on: Buy This Must-Own Dividend Stock While It’s DownDividend Boosts and Buybacks: Signs of Strength From These Firms More Dividend News This page (LON:AZN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts